DETTI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 274
EU - Europa 203
AS - Asia 119
OC - Oceania 1
SA - Sud America 1
Totale 598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 272
IE - Irlanda 81
HK - Hong Kong 74
IT - Italia 62
SE - Svezia 38
JO - Giordania 25
CN - Cina 10
RU - Federazione Russa 7
GB - Regno Unito 6
IN - India 4
DE - Germania 3
CA - Canada 2
FI - Finlandia 2
PH - Filippine 2
SG - Singapore 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
TR - Turchia 1
UA - Ucraina 1
Totale 598
Salva come PNG Salva come JPEG
Città #
Dublin 81
Chandler 80
Hong Kong 54
Ashburn 28
New York 16
West Jordan 15
Shanghai 9
Florence 8
Altamura 6
Lawrence 6
Moscow 6
Seattle 5
Boston 4
Fairfield 4
Princeton 4
Pune 4
Rome 4
Wilmington 4
Brescia 3
Buffalo 3
Garden City 3
Milan 3
Pontedera 3
San Diego 3
Cambridge 2
Empoli 2
Fiesole 2
Frankfurt am Main 2
Helsinki 2
Novate Milanese 2
Scarperia e San Piero 2
Southwark 2
Toronto 2
Woodbridge 2
Ann Arbor 1
Arezzo 1
Bari 1
Cabanatuan City 1
Chiari 1
Gorgonzola 1
Hillsboro 1
London 1
Los Angeles 1
Lucca 1
Medford 1
Nanjing 1
Norwalk 1
Padova 1
Ponte Buggianese 1
Prague 1
Quezon City 1
Sassari 1
Singapore 1
Sydney 1
São Paulo 1
Vienna 1
Wandsworth 1
Washington 1
Totale 400
Salva come PNG Salva come JPEG
Nome #
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 42
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 41
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 38
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 35
Regorafenib in glioblastoma recurrence: A case report 31
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 30
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 29
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 27
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials 27
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 26
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 25
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 24
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 22
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 21
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 20
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 20
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 18
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 18
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 18
Synchronous bilateral testicular germ cell tumour: Case report and review of the literature 17
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 16
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 16
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 15
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 12
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 9
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 8
Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques 6
Totale 611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 15 3 0 0 4 1 1 6 9
2022/2023330 10 27 8 18 35 80 53 25 60 1 5 8
2023/2024242 11 19 26 21 14 43 17 67 2 22 0 0
Totale 611